Quantitative proteomics for cardiac biomarker discovery using isoproterenol-treated nonhuman primates.
about
Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction.Evaluation of Cardiac Toxicity Biomarkers in Rats from Different Laboratories.Analysis of the plasma proteome using iTRAQ and TMT-based Isobaric labeling.Toxicoproteomics in human health and disease: an update.
P2860
Quantitative proteomics for cardiac biomarker discovery using isoproterenol-treated nonhuman primates.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Quantitative proteomics for ca ...... nol-treated nonhuman primates.
@ast
Quantitative proteomics for ca ...... nol-treated nonhuman primates.
@en
Quantitative proteomics for ca ...... nol-treated nonhuman primates.
@nl
type
label
Quantitative proteomics for ca ...... nol-treated nonhuman primates.
@ast
Quantitative proteomics for ca ...... nol-treated nonhuman primates.
@en
Quantitative proteomics for ca ...... nol-treated nonhuman primates.
@nl
prefLabel
Quantitative proteomics for ca ...... nol-treated nonhuman primates.
@ast
Quantitative proteomics for ca ...... nol-treated nonhuman primates.
@en
Quantitative proteomics for ca ...... nol-treated nonhuman primates.
@nl
P2093
P2860
P356
P1476
Quantitative proteomics for ca ...... nol-treated nonhuman primates.
@en
P2093
Benben Song
Jennifer K Miller
Mary J Tanga
Shufeng Liu
Toufan Parman
Xiaohua Liu
P2860
P304
P356
10.1021/PR500835W
P577
2014-11-07T00:00:00Z